A. Grant

发表

HIV-1 Nef mobilizes lipid rafts in macrophages through a pathway that competes with ABCA 1-dependent cholesterol effl ux

M. Bukrinsky, D. Sviridov, K. Gaus, 2012 .

Herpes simplex virus infection in human arterial cells. Implications in arteriosclerosis.

B. Weksler, D. Hajjar, D. Falcone, 1987, The Journal of clinical investigation.

Stimulation of the Liver X Receptor Pathway Inhibits HIV-1 Replication via Induction of ATP-Binding Cassette Transporter A1

F. Kashanchi, M. Bukrinsky, D. Sviridov, 2010, Molecular Pharmacology.

A multidonor ELISPOT study of IL-1β, IL-2, IL-4, IL-6, IL-13, IFN-γ and TNF-α release by cryopreserved human peripheral blood mononuclear cells

M. Tsang, S. Stark, C. Hartnett, 2002 .

Antiretroviral compounds and cholesterol efflux from macrophages.

M. Bukrinsky, D. Sviridov, A. Dart, 2009, Atherosclerosis.

Mutation of the ATP cassette binding transporter A1 (ABCA1) C-terminus disrupts HIV-1 Nef binding but does not block the Nef enhancement of ABCA1 protein degradation.

Angela Grant, M. Bukrinsky, D. Sviridov, 2010, Biochemistry.

Circulating Nef induces dyslipidemia in simian immunodeficiency virus-infected macaques by suppressing cholesterol efflux.

M. Bukrinsky, D. Sviridov, K. Mansfield, 2010, The Journal of infectious diseases.

HIV-1 Nef mobilizes lipid rafts in macrophages through a pathway that competes with ABCA1-dependent cholesterol efflux[S]

M. Bukrinsky, D. Sviridov, K. Gaus, 2012, Journal of Lipid Research.

Simultaneous detection of multiple cytokines in ELISPOT assays.

Chris Hartnett, Angela Grant, M. Tsang, 2005, Methods in molecular biology.

Fate of fibrinogen in human arterial intima.

E. B. Smith, G. Keen, A. Grant, 1990, Arteriosclerosis.

A cell-detachment solution can reduce background staining in the ELISPOT assay.

M. Tsang, C. Hartnett, A. Kalyuzhny, 2005, Methods in molecular biology.